for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Mayne Pharma Group Executes License & Supply Deal For Novel Oral Contraceptive In Australia

May 28 (Reuters) - Mayne Pharma Group Ltd:

* EXECUTES 20 YEAR LICENSE AND SUPPLY AGREEMENT FOR NOVEL ORAL CONTRACEPTIVE IN AUSTRALIA

* EXPECTED TO BE FILED WITH THERAPEUTIC GOODS ADMINISTRATION (TGA) IN 2020 WITH POTENTIAL LAUNCH IN SECOND HALF OF CALENDAR 2021

* ON APPROVAL, PRODUCT IS EXPECTED TO RECEIVE FIVE YEARS OF DATA EXCLUSIVITY FROM TGA

* LICENSE & SUPPLY DEAL WITH MITHRA PHARMACEUTICALS SA TO COMMERCIALISE E4/DRSP Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up